Iris Pharma is a world-leading Contract Research Organization (CRO) offering preclinical and clinical ophthalmology research services.
Iris Pharma works hand-in-hand with customers and has helped bring more than 70 ocular drugs and medical devices to international markets to date. The company is able to do this as efficiently as possible by maintaining a global view of the development process and by bringing personalized advice. Iris Pharma indeed addresses all ophthalmology challenges by offering programs and study designs that perfectly suit the needs of customers: therapeutic value assessment, full preclinical regulatory package, product value creation or à la carte studies.
Compliance with GLP, ICH-GCP and GCLP requirements; CIR agreement.